Benedict Financial Advisors Inc Novo Nordisk A S Transaction History

Benedict Financial Advisors Inc

  • $410 Million
  • Q4 2024

A detailed history of Benedict Financial Advisors Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Benedict Financial Advisors Inc holds 38,551 shares of NVO stock, worth $2.68 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
38,551
Previous 40,065 3.78%
Holding current value
$2.68 Million
Previous $4.77 Million 30.48%
% of portfolio
0.81%
Previous 1.13%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025
SELL
$85.0 - $120.04 $128,690 - $181,740
-1,514 Reduced 3.78%
38,551 $3.32 Million
Q3 2024

Oct 24, 2024
SELL
$119.07 - $145.42 $158,720 - $193,844
-1,333 Reduced 3.22%
40,065 $4.77 Million
Q2 2024

Jul 30, 2024
SELL
$122.71 - $146.91 $153,142 - $183,343
-1,248 Reduced 2.93%
41,398 $5.91 Million
Q1 2024

Apr 25, 2024
SELL
$102.11 - $135.92 $103,947 - $138,366
-1,018 Reduced 2.33%
42,646 $5.48 Million
Q4 2023

Jan 29, 2024
SELL
$87.78 - $105.45 $55,125 - $66,222
-628 Reduced 1.42%
43,664 $4.52 Million
Q3 2023

Oct 18, 2023
BUY
$90.94 - $199.54 $1.95 Million - $4.28 Million
21,457 Added 93.97%
44,292 $4.03 Million
Q2 2023

Aug 10, 2023
SELL
$155.98 - $172.65 $53,657 - $59,391
-344 Reduced 1.48%
22,835 $3.7 Million
Q1 2023

May 11, 2023
SELL
$132.34 - $159.14 $193,613 - $232,821
-1,463 Reduced 5.94%
23,179 $3.69 Million
Q4 2022

Feb 14, 2023
SELL
$102.55 - $135.33 $36,405 - $48,042
-355 Reduced 1.42%
24,642 $3.33 Million
Q3 2022

Nov 07, 2022
SELL
$95.28 - $116.93 $15,149 - $18,591
-159 Reduced 0.63%
24,997 $2.49 Million
Q2 2022

Jul 28, 2022
SELL
$103.24 - $121.81 $21,577 - $25,458
-209 Reduced 0.82%
25,156 $2.8 Million
Q1 2022

May 03, 2022
SELL
$93.1 - $112.54 $21,878 - $26,446
-235 Reduced 0.92%
25,365 $2.82 Million
Q4 2021

Feb 09, 2022
SELL
$95.88 - $117.08 $64,814 - $79,146
-676 Reduced 2.57%
25,600 $2.87 Million
Q3 2021

Oct 29, 2021
SELL
$84.42 - $106.62 $28,871 - $36,464
-342 Reduced 1.28%
26,276 $2.52 Million
Q2 2021

Aug 05, 2021
BUY
$67.66 - $84.76 $69,554 - $87,133
1,028 Added 4.02%
26,618 $2.23 Million
Q1 2021

May 10, 2021
BUY
$67.06 - $75.82 $35,474 - $40,108
529 Added 2.11%
25,590 $1.73 Million
Q4 2020

Feb 02, 2021
BUY
$63.89 - $73.8 $53,667 - $61,992
840 Added 3.47%
25,061 $1.75 Million
Q3 2020

Nov 03, 2020
BUY
$63.69 - $70.22 $34,965 - $38,550
549 Added 2.32%
24,221 $1.68 Million
Q2 2020

Jul 23, 2020
BUY
$58.54 - $67.94 $120,124 - $139,412
2,052 Added 9.49%
23,672 $1.55 Million
Q1 2020

Apr 21, 2020
BUY
$49.46 - $64.78 $451,322 - $591,117
9,125 Added 73.03%
21,620 $1.3 Million
Q4 2019

Feb 04, 2020
BUY
$49.86 - $58.26 $623,000 - $727,958
12,495 New
12,495 $723,000

Others Institutions Holding NVO

# of Institutions
1,887
Shares Held
335M
Call Options Held
11.9M
Put Options Held
10.6M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $157B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Benedict Financial Advisors Inc Portfolio

Follow Benedict Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benedict Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benedict Financial Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email